Ziel unserer Forschung ist es, virusbedingte Erkrankungen zu verstehen und neue Therapieansätze zu entwickeln.
The Leibniz-Institut für Virologie (LIV) is a nationally recognized Leibniz Institute dedicated to pioneering research in experimental virology. With a strong focus on viruses that impact current and future public health, the Leibniz-Institut für Virologie (LIV) is committed to both basic and applied research in alignment with its foundational aims.
Located at Martinistr. 52, Hamburg, 20251, DE, the Leibniz-Institut für Virologie (LIV) applies cutting-edge experimental research to develop innovative approaches for treating viral infections, including AIDS, influenza, hepatitis, and emerging viral diseases. The Leibniz-Institut für Virologie (LIV) aims to understand virus-induced diseases and create new therapeutic interventions.
The Leibniz-Institut für Virologie (LIV) is at the forefront of virological research and development. We invite the management of the Leibniz-Institut für Virologie (LIV) to create a customized and exclusive company showcase and product listing on our platform to further highlight its contributions and capabilities.
Other organizations in the same industry
This company is also known as